Skip to main content
Passa alla visualizzazione normale.


Pari opportunità

PATRIZIA DIANA

Multi or Single-Kinase Inhibitors to Counteract Drug Resistance in Cancer: What is New?

  • Authors: Pecoraro C.; Carbone D.; Cascioferro S.M.; Parrino B.; Diana P.
  • Publication year: 2023
  • Type: Articolo in rivista
  • Key words: allosteric inhibitors; anticancer drug combinations; covalent kinase inhibitors; kinase genetic aberration; polypharmacology; Small molecules kinase inhibitors
  • OA Link: http://hdl.handle.net/10447/580471

Abstract

The concept of protein kinase inhibition starts from the groundbreaking research on the role of these proteins in the regulation of fundamental processes, including proliferation, cell cycle, apoptosis, metabolism, and inflammation. Kinase genetic mutations, as well as overexpression and dysregulation, can contribute to the development of several diseases, including neoplasms, leading to relapses and resistance to standard drug chemotherapy [1-3].